127 plain-language articles on heart risk, the tests that measure it, what your numbers mean, and how the Cardio Res-Q assessments work. Start wherever your question is.
Pick the question closest to yours. Each section builds on the one before it, so you can also read straight through.
Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.
Four quick aids that route you to the right guide. Nothing you enter is saved.
Unfamiliar term? The YoungerMeMD glossary defines ApoB, Lp(a), hs-CRP, CAC and more.
Heart disease builds quietly for decades. These articles explain who is at risk, why normal results can mislead, and when it makes sense to look closer.
A normal cholesterol panel does not rule out heart disease. What a standard panel misses, which risks hide behind normal numbers, and what to check next.
What counts as a family history of early heart disease, how much it raises your own risk, what is inherited and what is not, and what to do about it.
Chest pain is still the most common heart attack symptom in women, but other signs are more likely. What to watch for, and when to call 911.
How heart disease risk builds through your 40s, 50s and 60s, what to check in each decade, and why the earlier decades matter most.
Heart risk rises around menopause as cholesterol, blood pressure and body fat shift. What changes, what early menopause means, and what to check.
How low testosterone relates to heart risk in men, what the large safety trial of testosterone therapy found, and why erectile dysfunction matters.
Chronic inflammation helps drive plaque in the arteries. What causes it, how it is measured, and which conditions raise inflammatory heart risk.
How plaque forms in artery walls over decades, the difference between soft and calcified plaque, why most of it causes no symptoms, and how it is found.
Heart disease often develops for years without symptoms. Why it stays silent, who is most likely to have it, and how it can be detected early.
PREVENT replaced the older heart risk calculator in US guidance. What goes into it, what low, borderline, intermediate and high risk mean, and its limits.
When to begin checking cholesterol, blood pressure and blood sugar, when imaging such as a calcium score is worth considering, and who should start early.
Heart age and vascular age compare your arteries with the average for your age. How they are estimated, how reliable they are, and what moves them.
Most clogged arteries cause no symptoms. Learn the 911 warning signs, the late signs such as angina, leg pain and TIA, and the tests that find plaque early.
Type 2 diabetes about doubles heart disease risk. See what drives it, why a calcium score of zero is less reassuring, and which numbers get checked.
Heart risk begins to rise at the prediabetes stage. Learn how large the increase is, what lifestyle trials showed, and which results are still unproven.
PCOS raises the chance of high blood pressure and type 2 diabetes. See what studies show about heart disease and stroke, and which checks guidelines advise.
Rheumatoid arthritis, lupus and psoriasis raise heart and stroke risk. Learn how much, why risk calculators underestimate it, and what gets checked.
Heart risk climbs as kidney function falls. See what eGFR and urine albumin mean for your heart and why the PREVENT calculator includes kidney function.
Sleep apnea is linked to high blood pressure and atrial fibrillation. Learn what CPAP trials did and did not show for preventing heart attack and stroke.
Preeclampsia, gestational diabetes and preterm birth are linked to higher heart risk years later. What the studies show and what gets checked.
South Asian ancestry is a recognized risk enhancer for heart disease. What population studies show, why calculators can read low, and what to check.
Heart risk drops within five years of quitting smoking, but some risk can linger for a decade or more. What cohort studies show for ex-smokers.
Lifelong runners and cyclists often have higher coronary calcium scores. What the studies found about plaque type, outcomes and what is still unknown.
Signs of familial hypercholesterolemia: LDL of 190 or higher, a family pattern of early heart disease, and visible deposits. Why relatives get tested.
Heart disease is the leading cause of death in people with fatty liver (MASLD/NAFLD). How much the risk rises, why, and what gets checked.
Belly fat is tied to heart disease more closely than BMI. Learn what visceral fat is, why waist size matters and why normal weight can hide risk.
Early heart attacks in men usually follow risk factors that can be found. See who is at risk before 50, why 10-year scores read low and what to check.
Gout is linked with more heart disease, but cause is unproven. See what studies show about flares, uric acid and heart risk, and what to check.
Chest radiation and some chemotherapy can raise heart risk for decades. Learn who is most affected and what heart follow-up for survivors involves.
An underactive thyroid raises LDL cholesterol and an overactive one raises AFib risk. See why thyroid status is checked before cholesterol decisions.
E-cigarettes raise heart rate and blood pressure in the short term, but long-term heart data are missing. An honest look at what studies show so far.
Mediterranean and DASH eating patterns have the strongest heart evidence. See what the trials found, where the proof is thin, and what both share.
Guidelines advise 150 minutes of moderate activity a week plus strength work. See what large studies show about smaller amounts, steps and limits.
Short, long and irregular sleep are all linked to more heart disease in large studies. Learn what the evidence shows and what it cannot prove.
Older studies said moderate drinking protects the heart. Newer analyses doubt it. See what the evidence shows on blood pressure, AFib and stroke.
Chronic stress and depression are linked to more heart attacks. See what INTERHEART and later studies found, and why risk-factor control still comes first.
Weight loss lowers blood pressure, triglycerides and blood sugar. See what the Look AHEAD trial and newer medicine trials found about heart attacks.
Saturated fat raises LDL more than the cholesterol in food. See what trials and egg studies found, why people respond differently, and what guidelines say.
Soluble fiber from oats, beans and psyllium lowers LDL cholesterol by a modest amount. See the trial numbers, the limits, and common food sources.
Long daily sitting is linked with higher cardiovascular risk. See what large studies found, where risk rises, and how much activity offsets it.
Moderate coffee is linked with slightly lower heart risk in large studies. Learn why unfiltered coffee raises LDL and what trials show about palpitations.
Calcium scores, ApoB, Lp(a), CIMT, hs-CRP, EndoPAT. Each guide covers what the test measures, how to read the result, and what it cannot tell you.
What a coronary artery calcium scan measures, what CAC score ranges mean, who the test may help, and what it cannot tell you about heart risk.
A calcium score of zero is reassuring, but not permanent and not proof of clean arteries. What a zero means, when it is less reassuring, and when to rescan.
The same calcium score means different things at 45 and 70. How CAC scores compare by age and sex, what a percentile is, and when a score is high for you.
A high coronary calcium score is not an emergency, but it changes the plan. What scores of 100, 300 and 1,000 mean and the usual next steps.
A calcium score looks for plaque. A stress test looks for blocked blood flow. What each one answers, who each is for, and why one cannot replace the other.
A carotid intima-media thickness ultrasound looks at artery wall thickness and early plaque. What it measures, its limits, and when it may be considered.
CIMT is an ultrasound of the neck arteries. CAC is a CT scan of the heart arteries. What each shows, how strong the evidence is, and why some people get both.
ApoB counts the cholesterol-carrying particles that cause plaque. How it differs from LDL cholesterol, when the two disagree, and what the result is used for.
Lp(a) is an inherited cholesterol particle linked to early heart disease. Why it is usually tested once, what a high result means, and what can be done.
High-sensitivity CRP measures low-grade inflammation linked to heart risk. What the ranges mean, what throws the result off, and how it is used.
EndoPAT measures how well your blood vessel lining works, not plaque. How the fingertip test is done, what the result means, and its limits.
If a parent or sibling had early heart disease, which tests add real information: Lp(a), ApoB, a calcium score, and when to have each.
What a preventive heart risk assessment includes: the risk estimate, history, advanced labs, CAC and CIMT imaging, EndoPAT, and the plan that follows.
A calcium score of 1 to 99 means plaque has started. How it differs from zero, why age changes the reading, and the usual next steps.
A calcium score of 100 to 399 signals moderate plaque. What it means for heart risk and statin decisions, and what stays the same.
A calcium score of 400 or more means extensive plaque and high long-term risk. Why it is not an emergency without symptoms and what happens next.
A calcium score over 1,000 carries risk similar to known heart disease. What cohort studies show, typical follow-up, and what not to assume.
In your 40s a calcium score of zero is expected and any calcium is meaningful. What a positive score means and who should scan this early.
Calcium scores vary widely in the 50s. What zero, low and higher scores mean for men and for women, and when the result changes a treatment decision.
Most people in their 60s and 70s have some coronary calcium. Why the amount and percentile matter more, and what a score of zero means later in life.
A higher calcium score on a repeat scan is expected. How much change is normal, why statins can raise the number, and why rescans have limited value.
See where your ApoB falls among US adults and which decision levels (90, 70 and 60 mg/dL) lipid specialists use for each heart risk category.
A normal LDL with a high ApoB means more cholesterol particles than LDL suggests. Learn why it happens, what studies show and what to ask.
Lp(a) is reported in mg/dL or nmol/L, and the two do not convert exactly. See the thresholds in each unit and how to read your own lab report.
Diet, exercise and current drugs do not lower Lp(a). What a high result changes: tighter control of other risk factors and testing for relatives.
A high hs-CRP often comes from infection, excess weight, autoimmune disease or oral estrogen, not your arteries. Here is when to repeat the test.
What triglycerides are, the level categories from normal to severe, what raises them, and why ApoB and remnant particles explain the heart risk.
Non-HDL cholesterol is total cholesterol minus HDL. Learn how to calculate it, the goals by risk level, and why it beats LDL when triglycerides run high.
Very high HDL cholesterol is not extra protection, and drugs that raised HDL failed to prevent heart attacks. Here is what a low HDL really signals.
LDL cholesterol goals depend on your risk: below 100, 70 or 55 mg/dL under the 2026 US guideline. See the table and how to find your category.
High homocysteine is linked with heart disease, but B vitamin trials that lowered it did not prevent heart attacks. What your result means.
How A1c ranges for prediabetes and diabetes relate to heart attack and stroke risk, where A1c falls short as a predictor, and what can skew it.
How to calculate your triglyceride-to-HDL ratio, what a high result suggests about insulin resistance, and why it is not a guideline measure.
How to work out your total-to-HDL cholesterol ratio, what it predicts, what it hides, and why guidelines base treatment on LDL and not the ratio.
What each line of a cholesterol test means: total, LDL (calculated or direct), HDL, triglycerides and non-HDL, plus whether you need to fast.
How to read a CIMT report: wall thickness, percentile or vascular age, and plaque. What each line means and how much weight it deserves.
Low vitamin D is linked with heart disease, but large trials of supplements did not reduce heart attacks or strokes. What that means for you.
A 10-year heart risk of 3% to under 10% is a gray zone. How risk enhancers and a calcium score help settle it, and how the decision is made.
A calcium score counts calcified plaque with no dye. A CT angiogram uses contrast to show soft plaque and narrowing. See who each scan is for.
ApoB counts plaque-forming particles. Non-HDL cholesterol is free arithmetic on a standard panel. How closely they agree and when ApoB adds more.
CIMT measures artery wall thickness as a risk marker. A carotid Doppler grades narrowing. Why the two are not interchangeable and who needs which.
EndoPAT checks how well small arteries widen. A stress test looks for reduced blood flow to the heart. Neither is a general screening test.
A standard lipid panel compared with ApoB, Lp(a) and hs-CRP: what each added test shows, what guidelines say about it, and who gains the most.
Lp(a) is an LDL-like particle set by your genes. Learn why it hides inside the LDL number and why statins lower one but not the other.
hs-CRP, standard CRP and ESR all measure inflammation, but only hs-CRP is used for heart risk. What each test is for and how to read them.
ECG, echocardiogram, stress test, calcium score and CT angiogram each answer a different question. See what each one shows and who it is for.
PREVENT replaced the Pooled Cohort Equations for heart risk. See what changed, why most estimates fell and why a lower number is not better news.
A calcium heart scan answers one question. A full-body CT or MRI looks at everything. Compare radiation, incidental findings and the evidence.
Soft plaque and calcified plaque are stages of one disease. Learn which is linked to heart attacks, what a calcium score misses and what treatment does.
A low 10-year heart risk can sit beside a high 30-year risk, especially under 60. See what each estimate means and how to use the two together.
A heart attack is a blocked artery, cardiac arrest is a heart that stops pumping, heart failure is a weak pump. Know the signs and when to call 911.
How statins lower LDL cholesterol, how much large trials found they reduce heart attacks and strokes, and which groups US guidelines have in mind.
What blinded trials found about statin muscle aches, the nocebo effect, diabetes risk and liver tests, and what to tell your prescriber about symptoms.
What ezetimibe, PCSK9 inhibitors, inclisiran and bempedoic acid do, what their trials showed and in whom, and where the evidence is still missing.
What the SELECT trial and the diabetes outcome trials found about GLP-1 medicines and heart attack and stroke risk, who was studied, and what is unknown.
Why daily aspirin is no longer routine for people without heart disease: what ASPREE, ARRIVE and ASCEND found, and why stopping needs a doctor's input.
What trials show about lowering LDL cholesterol further, the goals guidelines set for people at very high risk, and what is known about very low LDL.
REDUCE-IT, STRENGTH and VITAL gave different answers on omega-3 and heart risk. What each trial tested, who was in it, and the atrial fibrillation signal.
Red yeast rice, plant sterols, berberine and fiber: what trials found for LDL cholesterol, how they compared with a statin, and the quality problems.
Statins lower CoQ10 in the blood, but trials of CoQ10 for statin muscle aches conflict. What each study found and what has better support.
Trials of intensive LDL lowering measured small reductions in coronary plaque volume. What they found, in whom, and why stabilization is the real goal.
When is lifestyle change alone reasonable for heart risk, and when do guidelines favor adding medication? What studies show about each, and why both matter.
What happens after you start a statin: when the follow-up blood test is due, how far LDL usually falls, what trials show about side effects, what to ask.
What lowers ApoB and roughly by how much: saturated fat swaps, soluble fiber, weight loss, triglycerides and cholesterol drug classes, from pooled trials.
How much saturated fat swaps, soluble fiber, weight loss, plant sterols and the portfolio diet lower LDL, and when lifestyle change alone is not enough.
Straight answers about the Cardio Res-Q assessments: what is included, what it costs, how it compares with other options, and who should not book.
The $775 Comprehensive and $999 Enhanced Cardio Res-Q assessments compared: what each includes, what the imaging adds, and how to choose.
How a Cardio Res-Q assessment works from booking to results: how to prepare, the labs and imaging, the review with your provider, and what comes after.
What you receive after a Cardio Res-Q assessment: your lab and imaging results explained, your risk profile, and a personalized heart protection plan.
A cardiologist diagnoses and treats heart disease. Cardio Res-Q looks for risk before it becomes disease. How the two differ and when you need which.
An executive physical screens everything in a day. Cardio Res-Q goes deep on heart risk only. How they compare on scope, cost and follow-up.
What Cardio Res-Q costs, what each price includes, why it is direct-pay rather than billed to insurance, and how HSA and FSA funds fit in.
Taking a statin lowers risk but does not remove it. What an assessment can show when you are already treated, and what it cannot change.
Cardio Res-Q suits adults who want a deeper look at heart risk before symptoms. Who benefits most, who does not need it, and who needs a cardiologist instead.
Before paying for preventive heart screening anywhere, ask these nine questions about the tests, who reads them, the costs, and what happens with results.
What to do before a coronary calcium scan, what happens at the imaging center, and how the scan fits into the Cardio Res-Q Enhanced Assessment.
Which earlier labs and heart scans are worth bringing to a Cardio Res-Q assessment, how to get copies, and what to ask our team before you book.
A printable list of questions for your cardiologist or primary care doctor about calcium score, ApoB, Lp(a), CIMT and your Cardio Res-Q plan.
Lp(a) once, lipids after a treatment change, calcium scans years apart: how often each heart test is worth repeating and what the guidance says.
Cardio Res-Q labs need a 10 to 12 hour fast. Learn which results a meal changes, what you can drink, and what to ask our team about medications.
How Cardio Res-Q results fit with care from your cardiologist or primary care doctor, who handles what, and how to keep everyone on one plan.
Who gains the most from preventive heart testing, who gains little, what the evidence shows, and what Cardio Res-Q costs at $775 and $999.
The optional $279 membership and $125 Cardio Res-Q Specialty Treatment Plan: what each is listed as including, and what to ask before enrolling.
Calcium heart scan cost near Philadelphia (patients report about $100 to $200), how to find an imaging center, what to ask, and how Cardio Res-Q uses it.
ApoB and Lp(a) are in both Cardio Res-Q assessments ($775, $999) in Conshohocken: labs a week before your consult, a 10 to 12 hour fast, results explained.
The Cleveland HeartLab panel reports Lp(a), ApoB, hs-CRP, oxidized LDL and small dense LDL. What each one shows and how strong the evidence is.
What a cardiologist is, what integrative prevention care adds and cannot do, and when you need a cardiologist. Dr. Varano is a D.O. and integrative physician.
This guide is general education, not medical advice, and it is not for emergencies. If you have chest pain, shortness of breath or other symptoms of a heart attack or stroke, call 911.
Cardio Res-Q brings advanced labs, arterial imaging and Dr. Varano’s clinical evaluation into one prevention plan. Assessments start at $775.
This page is for general educational purposes and does not constitute medical advice. Individual results vary. Therapies are provided only after clinical evaluation and where medically appropriate. Speak with a YoungerMeMD provider about your specific needs.